Browse Category

SHA:688347.SS News 18 January 2026 - 2 February 2026

Hua Hong Semiconductor Class A share price: what to watch as 688347 heads into Feb. 12 Q4 results

Hua Hong Semiconductor Class A share price: what to watch as 688347 heads into Feb. 12 Q4 results

Hua Hong Semiconductor’s Shanghai-listed shares closed at 155.10 yuan on Friday, up 0.38%, outperforming the SSE Composite, which fell 0.96%. The company will release unaudited fourth-quarter 2025 results after trading on Feb. 12, with a board meeting set for that morning. An investor briefing will follow from 17:00 to 18:00 local time. Mainland markets reopen Monday after the weekend break.
Hua Hong Semiconductor Class A shares jump to 140 yuan — but a margin-rule shift is the next test

Hua Hong Semiconductor Class A shares jump to 140 yuan — but a margin-rule shift is the next test

Hua Hong Semiconductor’s Shanghai-listed shares closed up 6.9% at 140 yuan, near a 52-week high, valuing the company at about 184 billion yuan. China’s chip stocks outperformed as traders eyed Jan. 19, when exchanges will raise margin requirements for leveraged stock buys. Hua Hong plans to acquire nearly all of Shanghai Huali Microelectronics for 8.27 billion yuan in new shares, pending approvals.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop